Molecular Partners AG

Research Molecular Partners AG (MOLN) on Bullrun: market cap USD 164.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMOLN
ExchangeNASDAQ
CountrySwitzerland
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
Market capUSD 164.30M
Financial periodQ1 2026
RevenueCHF 0
Net income-CHF 13.14M
Free cash flow-CHF 48.69M

Valuation Snapshot

latest market cap is USD 164.30M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CHF 0	-CHF 61.65M	-CHF 51.97M	n/a	-2.99	CHF 82.65M	CHF 3.64M	CHF 80.33M
FY2024	CHF 4.97M	-CHF 54.04M	-CHF 59.97M	n/a	-2.88	CHF 63.87M	CHF 2.44M	CHF 141.64M
FY2023	n/a	n/a	-CHF 59.81M	n/a	-3.18	CHF 67.31M	CHF 3.65M	CHF 176.43M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 164.30M	n/a	n/a	n/a
2025	2025-12-31	USD 163.12M	n/a	n/a	n/a
2024	2024-12-31	USD 175.10M	n/a	n/a	n/a
2023	2023-12-29	USD 137.33M	n/a	n/a	n/a
2022	2022-12-30	USD 236.09M	1.7	n/a	n/a
2021	2021-12-31	USD 619.37M	n/a	n/a	n/a

About Molecular Partners AG

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia;

Related stock research

Switzerland stocks Switzerland Healthcare stocks A-Z stock index

Other Healthcare stocks

MOLECULAR PARTNERS SF 1 (6ML) AC Immune SA (ACIU) Addex Therapeutics Ltd (ADXN) Bachem Holding AG (BANB) BB Biotech AG (BBZA) Bioversys AG (BIOV) Basilea Pharmaceutica AG (BSLN) CARDERO RESOURCE (CR5) CRISPR Therapeutics AG (CRSP) Idorsia Ltd (IDIA) MoonLake Immunotherapeutics - Class A (MLTX) NLS Pharmaceutics Ltd (NCEL)

Frequently asked questions

What is Molecular Partners AG's market cap?

Molecular Partners AG's market capitalization is USD 164.30M.

What does Molecular Partners AG do?

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.